Abstract
Capsule endoscopy (CE) represents a significant advance in the investigation of small bowel diseases. Twothirds of Crohn’s disease (CD) patients have small bowel involvement at diagnosis. Study of small intestine mucosa by CE may have a strong impact on CD management in a near future. CE may be superior to small bowel cross-sectional imaging for detection of mucosal lesions consistent with CD and a normal CE has a high negative predictive value for active small bowel CD. A GI imaging study should generally precede CE to rule out complications such as fistulas and strictures. In established CD, CE may be useful in patients with unexplained symptoms when other investigations are inconclusive, if this will alter management. The low specificity of CE is its main drawback. Furthermore, there are no validated CD diagnosis criteria for CE and no severity indexes have been independently validated. The role of CE in evaluating mucosal healing and postoperative recurrence will require additional investigation.
Keywords: Capsule endoscopy, Crohn’s disease, small bowel diseases, cross-sectional imaging, mucosal lesions, GI imaging, mucosal healing, detection, gastrointestinal (GI), inflammatory bowel disease unclassified (IBDU).
Current Drug Targets
Title:Capsule Endoscopy in Crohn’s Disease
Volume: 13 Issue: 10
Author(s): Jean-Baptiste Chevaux, Gionata Fiorino, Muriel Frederic and Laurent Peyrin-Biroulet
Affiliation:
Keywords: Capsule endoscopy, Crohn’s disease, small bowel diseases, cross-sectional imaging, mucosal lesions, GI imaging, mucosal healing, detection, gastrointestinal (GI), inflammatory bowel disease unclassified (IBDU).
Abstract: Capsule endoscopy (CE) represents a significant advance in the investigation of small bowel diseases. Twothirds of Crohn’s disease (CD) patients have small bowel involvement at diagnosis. Study of small intestine mucosa by CE may have a strong impact on CD management in a near future. CE may be superior to small bowel cross-sectional imaging for detection of mucosal lesions consistent with CD and a normal CE has a high negative predictive value for active small bowel CD. A GI imaging study should generally precede CE to rule out complications such as fistulas and strictures. In established CD, CE may be useful in patients with unexplained symptoms when other investigations are inconclusive, if this will alter management. The low specificity of CE is its main drawback. Furthermore, there are no validated CD diagnosis criteria for CE and no severity indexes have been independently validated. The role of CE in evaluating mucosal healing and postoperative recurrence will require additional investigation.
Export Options
About this article
Cite this article as:
Chevaux Jean-Baptiste, Fiorino Gionata, Frederic Muriel and Peyrin-Biroulet Laurent, Capsule Endoscopy in Crohn’s Disease, Current Drug Targets 2012; 13 (10) . https://dx.doi.org/10.2174/138945012802429732
DOI https://dx.doi.org/10.2174/138945012802429732 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Pannexin Channels: The Emerging Therapeutic Targets
Current Drug Targets Ezetimibe and Reactive Oxygen Species
Current Vascular Pharmacology Pathogenesis and Immune Status in COVID-19 Pneumonia - A Minireview
Coronaviruses 19F: A Versatile Reporter for Non-Invasive Physiology and Pharmacology Using Magnetic Resonance
Current Medicinal Chemistry Adenosine and ATP Receptors in the Brain
Current Topics in Medicinal Chemistry Current Status of Imaging Infections with Radiolabeled Anti-Infective Agents
Anti-Infective Agents in Medicinal Chemistry Toxics of Tobacco Smoke and Cardiovascular System: From Functional to Cellular Damage
Current Pharmaceutical Design On the Biomaterials for Nanostructured Ocular Therapeutics
Current Organic Chemistry Restoring the Dysfunctional Endothelium
Current Pharmaceutical Design What Characterizes Endothelial Dysfunction in Preeclampsia? -The Action of NO and the Production of Prostacyclin is Reduced, While EDHF is Preserved in Omental Resistance Arteries in Preeclamptic Women
Current Women`s Health Reviews Pathophysiology of Blood-Brain Barrier in Brain Injury in Cold and Hot Environments: Novel Drug Targets for Neuroprotection
CNS & Neurological Disorders - Drug Targets Novel Agents Targeting Nitric Oxide
Current Vascular Pharmacology Protective Effects of Anesthetics on Vascular Function Related to K<sup>+</sup> Channels
Current Pharmaceutical Design Potential Role of Rho-Associated Protein Kinase Inhibitors for Glaucoma Treatment
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Moxifloxacin Based Triple Therapy as Alternative to Standard Therapy in <i>Helicobacter Pylori</i> Eradication
Anti-Infective Agents Effect of Aglycon and Glycoside Flavonoid-Enriched Extracts Obtained from Buxus sempervirens L. on Glucose and Lipid Metabolism in Diabetic Rats
Cardiovascular & Hematological Agents in Medicinal Chemistry Recent Patents on Emerging Therapeutics for the Treatment of Glaucoma, Age Related Macular Degeneration and Uveitis
Recent Patents on Biomedical Engineering (Discontinued) Endothelial Dysfunction and Platelet Hyperaggregation in Type 2 Diabetes Mellitus: The Era of Novel Anti-diabetic Agents
Current Medicinal Chemistry The Role of Chest High Resolution CT and RT-PCR in Diagnosis of Different Stages of Coronavirus (COVID-19) Pneumonia
New Emirates Medical Journal Microvascular Function/Dysfunction Downstream a Coronary Stenosis
Current Pharmaceutical Design